BrainStorm Cell Therapeutics
BCLI
#9868
Rank
$6.43 M
Marketcap
$1.21
Share price
7.08%
Change (1 day)
572.22%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): -$0.59

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.59. In 2022 the company made an earnings per share (EPS) of -$0.66 an increase over its 2021 EPS that were of -$0.68.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.59-10.61%
2022-$0.66-2.94%
2021-$0.68-37.04%
2020-$1.081.89%
2019-$1.0651.43%
2018-$0.70159.26%
2017-$0.27-3.57%
2016-$0.28-37.78%
2015-$0.45-33.82%
2014-$0.6836%
2013-$0.5011.11%
2012-$0.4550%
2011-$0.30-50%
2010-$0.60-233.33%
2009$0.45-142.86%
2008-$1.05-65%
2007-$3.00
2005$0.99-108.03%
2004-$12.3313203.07%
2003-$0.09272

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$4.39-844.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.69 864.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.01 579.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.46-3,228.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.85 44.07%๐Ÿ‡บ๐Ÿ‡ธ USA